Literature DB >> 24122784

Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer.

Areej El-Jawahri1, Lara Traeger, Elyse R Park, Joseph A Greer, William F Pirl, Inga T Lennes, Vicki A Jackson, Emily R Gallagher, Jennifer S Temel.   

Abstract

BACKGROUND: Patients' perception of their prognosis has an impact on their decisions about medical care. However, the relations between prognostic understanding and quality of life (QoL) and mood are unknown. The objectives of this study were to assess perceptions of prognosis and preferences for prognostic information among patients with advanced cancer and to explore the associations of prognostic understanding with QoL and mood.
METHODS: Fifty patients were assessed within 6 to 12 weeks of initiating chemotherapy for advanced gastrointestinal cancers. A 13-item questionnaire was used to assess patients' information preferences, perceptions of their prognosis and goal of therapy, and communication about end-of-life care. The Functional Assessment of Cancer Therapy-General and the Hospital Anxiety and Depression Scale were used to assess QoL and mood, respectively.
RESULTS: Fifty of 62 (80%) consecutive, eligible patients were enrolled. Thirty-eight of 50 patients (75%) wanted to know as many details as possible about their cancer diagnosis and treatment. However, 25 of 50 patients (50%) stated that the goal of therapy was to "cure their cancer," and only 10 of 49 patients (22%) reported having a discussion about end-of-life preferences with their oncologist. Patients who acknowledged their illness as terminal reported lower QoL (P=.005) and higher anxiety (P=.003) compared with those who did not perceive themselves as being terminally ill.
CONCLUSIONS: Although patients desired detailed information about their illness, half incorrectly perceived their cancer as curable. Accurate prognostic understanding was associated with lower QoL and worse anxiety. Interventions to improve patients' prognostic understanding while providing adequate psychosocial support are warranted.
© 2013 American Cancer Society.

Entities:  

Keywords:  advanced cancer; illness understanding; mood; prognostic understanding; quality of life; supportive care

Mesh:

Year:  2013        PMID: 24122784     DOI: 10.1002/cncr.28369

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  68 in total

1.  Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members.

Authors:  Shin Hye Yoo; Jihye Lee; Jung Hun Kang; Chi Hoon Maeng; Yu Jung Kim; Eun-Kee Song; Youngil Koh; Hwan-Jung Yun; Hyun-Jeong Shim; Jung Hye Kwon; Eun Mi Nam; EunKyo Kang; Jiyeon Choo; Young Ho Yun
Journal:  Support Care Cancer       Date:  2019-11-26       Impact factor: 3.603

Review 2.  Current state of the art and science of patient-clinician communication in progressive disease: patients' need to know and need to feel known.

Authors:  Liesbeth M van Vliet; Andrew S Epstein
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

3.  Early Integrated Telehealth versus In-Person Palliative Care for Patients with Advanced Lung Cancer: A Study Protocol.

Authors:  Isaac S Chua; Finly Zachariah; William Dale; Josephine Feliciano; Laura Hanson; Leslie Blackhall; Tammie Quest; Kimberly Curseen; Carl Grey; Ramona Rhodes; Laura Shoemaker; Maria Silveira; Stacy Fischer; Sean O'Mahony; Kostantinos Leventakos; Chardria Trotter; Isabella Sereno; Mihir Kamdar; Jennifer Temel; Joseph A Greer
Journal:  J Palliat Med       Date:  2019-09       Impact factor: 2.947

4.  Communication with children about a parent's advanced cancer and measures of parental anxiety and depression: a cross-sectional mixed-methods study.

Authors:  Claire E Hailey; Justin M Yopp; Allison M Deal; Deborah K Mayer; Laura C Hanson; Gili Grunfeld; Donald L Rosenstein; Eliza M Park
Journal:  Support Care Cancer       Date:  2017-08-07       Impact factor: 3.603

5.  Illness Understanding and Advance Care Planning in Patients with Advanced Lymphoma.

Authors:  Kelly M Trevino; Sarah C Rutherford; Chrystal Marte; Daniel Jie Ouyang; Peter Martin; Holly G Prigerson; John P Leonard
Journal:  J Palliat Med       Date:  2019-10-18       Impact factor: 2.947

6.  Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303.

Authors:  Jennifer S Temel; Jeff Sloan; Tyler Zemla; Joseph A Greer; Vicki A Jackson; Areej El-Jawahri; Mihir Kamdar; Arif Kamal; Craig D Blinderman; Jacob Strand; Dylan Zylla; Christopher Daugherty; Muhummad Furqan; Jennifer Obel; Mohammad Razaq; Eric J Roeland; Charles Loprinzi
Journal:  J Palliat Med       Date:  2020-02-07       Impact factor: 2.947

7.  Elucidating patient-perceived role in "decision-making" among African Americans receiving lung cancer care through a county safety-net system.

Authors:  Simon Craddock Lee; Emily G Marks; Joanne M Sanders; Deborah J Wiebe
Journal:  J Cancer Surviv       Date:  2015-06-16       Impact factor: 4.442

8.  A Randomized Trial of Acceptability and Effects of Values-Based Advance Care Planning in Outpatient Oncology: Person-Centered Oncologic Care and Choices.

Authors:  Andrew S Epstein; Eileen M O'Reilly; Elyse Shuk; Danielle Romano; Yuelin Li; William Breitbart; Angelo E Volandes
Journal:  J Pain Symptom Manage       Date:  2018-05-02       Impact factor: 3.612

9.  Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer.

Authors:  Jennifer A Shin; Areej El-Jawahri; Amanda Parkes; Stephen M Schleicher; Helen P Knight; Jennifer S Temel
Journal:  J Palliat Med       Date:  2016-04-28       Impact factor: 2.947

10.  Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Authors:  A El-Jawahri; H T Kim; D P Steensma; A M Cronin; R M Stone; C D Watts; Y-B Chen; C S Cutler; R J Soiffer; G A Abel
Journal:  Bone Marrow Transplant       Date:  2016-03-21       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.